Class information for:
Level 1: CD21//CR2//C3D

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
9963 1103 41.8 75%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
350 3       COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY 35656
363 2             COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 17354
9963 1                   CD21//CR2//C3D 1103

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CD21 authKW 486810 4% 37% 48
2 CR2 authKW 298955 2% 60% 18
3 C3D authKW 241561 2% 36% 24
4 GP350 authKW 221459 1% 100% 8
5 SOLUBLE CD21 authKW 203839 1% 82% 9
6 COMPLEMENT RECEPTOR 2 authKW 186851 1% 75% 9
7 CR 2 authKW 147634 1% 67% 8
8 CR2 CD21 authKW 142365 1% 86% 6
9 COMPLEMENT RECEPTOR authKW 133630 3% 16% 31
10 ANTI CR2 MOAB authKW 110729 0% 100% 4

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Immunology 21387 66% 0% 726
2 Virology 2562 12% 0% 132
3 Medicine, Research & Experimental 327 8% 0% 83
4 Biochemistry & Molecular Biology 111 13% 0% 143
5 Hematology 93 4% 0% 40
6 Cell Biology 86 7% 0% 73
7 Infectious Diseases 17 2% 0% 22
8 Biophysics 15 3% 0% 28
9 Biochemical Research Methods 13 2% 0% 24
10 Biotechnology & Applied Microbiology 12 3% 0% 33

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 U354 49209 0% 44% 4
2 IMMUNOL IMM 19 36908 0% 67% 2
3 BILSTON GLEN IND ESTATE 27682 0% 100% 1
4 BIOPROC DEV IL 27682 0% 100% 1
5 CANC TRAINING MICROBIOL 27682 0% 100% 1
6 CANC TRAINING SURG 27682 0% 100% 1
7 CEA IMMUNOCHIM 27682 0% 100% 1
8 CEAGDRDCCH IMMUNOCHIM 27682 0% 100% 1
9 CNRSUA 1301GENET VIRUS ONCOGENES 27682 0% 100% 1
10 DBMS ICHCEAG 27682 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF IMMUNOLOGY 16946 16% 0% 181
2 EUROPEAN JOURNAL OF IMMUNOLOGY 7786 6% 0% 61
3 MOLECULAR IMMUNOLOGY 7567 4% 1% 44
4 IMMUNOLOGY LETTERS 4472 3% 1% 30
5 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 3300 2% 0% 26
6 COMPREHENSIVE IMMUNOLOGY 2515 0% 9% 1
7 INTERNATIONAL IMMUNOLOGY 2206 2% 0% 18
8 IMMUNOLOGY 1937 2% 0% 25
9 JOURNAL OF EXPERIMENTAL MEDICINE 1858 3% 0% 29
10 AIDS RESEARCH 1649 0% 3% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CD21 486810 4% 37% 48 Search CD21 Search CD21
2 CR2 298955 2% 60% 18 Search CR2 Search CR2
3 C3D 241561 2% 36% 24 Search C3D Search C3D
4 GP350 221459 1% 100% 8 Search GP350 Search GP350
5 SOLUBLE CD21 203839 1% 82% 9 Search SOLUBLE+CD21 Search SOLUBLE+CD21
6 COMPLEMENT RECEPTOR 2 186851 1% 75% 9 Search COMPLEMENT+RECEPTOR+2 Search COMPLEMENT+RECEPTOR+2
7 CR 2 147634 1% 67% 8 Search CR+2 Search CR+2
8 CR2 CD21 142365 1% 86% 6 Search CR2+CD21 Search CR2+CD21
9 COMPLEMENT RECEPTOR 133630 3% 16% 31 Search COMPLEMENT+RECEPTOR Search COMPLEMENT+RECEPTOR
10 ANTI CR2 MOAB 110729 0% 100% 4 Search ANTI+CR2+MOAB Search ANTI+CR2+MOAB

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 KULIK, L , CHEN, KA , HUBER, BT , HOLERS, VM , (2011) HUMAN COMPLEMENT RECEPTOR TYPE 2 (CR2/CD21) TRANSGENIC MICE PROVIDE AN IN VIVO MODEL TO STUDY IMMUNOREGULATORY EFFECTS OF RECEPTOR ANTAGONISTS.MOLECULAR IMMUNOLOGY. VOL. 48. ISSUE 6-7. P. 883-894 72 84% 1
2 HANNAN, JP , (2016) THE STRUCTURE-FUNCTION RELATIONSHIPS OF COMPLEMENT RECEPTOR TYPE 2 (CR2; CD21).CURRENT PROTEIN & PEPTIDE SCIENCE. VOL. 17. ISSUE 5. P. 463 -487 101 44% 1
3 KULIK, L , HEWITT, FB , WILLIS, VC , RODRIGUEZ, R , TOMLINSON, S , HOLERS, VM , (2015) A NEW MOUSE ANTI-MOUSE COMPLEMENT RECEPTOR TYPE 2 AND 1 (CR2/CR1) MONOCLONAL ANTIBODY AS A TOOL TO STUDY RECEPTOR INVOLVEMENT IN CHRONIC MODELS OF IMMUNE RESPONSES AND DISEASE.MOLECULAR IMMUNOLOGY. VOL. 63. ISSUE 2. P. 479 -488 52 81% 0
4 TOAPANTA, FR , ROSS, TM , (2006) COMPLEMENT-MEDIATED ACTIVATION OF THE ADAPTIVE IMMUNE RESPONSES - ROLE OF C3D IN LINKING THE INNATE AND ADAPTIVE IMMUNITY.IMMUNOLOGIC RESEARCH. VOL. 36. ISSUE 1-3. P. 197-210 57 84% 34
5 BOACKLE, SA , (2005) ROLE OF COMPLEMENT RECEPTOR 2 IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS.MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION X: INNATE IMMUNITY. VOL. 560. ISSUE . P. 141 -147 53 85% 2
6 KOVACS, JM , HANNAN, JP , EISENMESSER, EZ , HOLERS, VM , (2009) MAPPING OF THE C3D LIGAND BINDING SITE ON COMPLEMENT RECEPTOR 2 (CR2/CD21) USING NUCLEAR MAGNETIC RESONANCE AND CHEMICAL SHIFT ANALYSIS.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 284. ISSUE 14. P. 9513-9520 45 87% 12
7 HAAS, KM , TEDDER, TF , (2005) ROLE OF THE CD19 AND CD21/35 RECEPTOR COMPLEX IN INNATE IMMUNITY, HOST DEFENSE AND AUTOMMUNITY.MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION X: INNATE IMMUNITY. VOL. 560. ISSUE . P. 125 -139 64 62% 17
8 NIELSEN, CH , FISCHER, EM , LESLIE, RGQ , (2000) THE ROLE OF COMPLEMENT IN THE ACQUIRED IMMUNE RESPONSE.IMMUNOLOGY. VOL. 100. ISSUE 1. P. 4-12 66 65% 57
9 TOLNAY, M , TSOKOS, GC , (1998) COMPLEMENT RECEPTOR 2 IN THE REGULATION OF THE IMMUNE RESPONSE.CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. VOL. 88. ISSUE 2. P. 123 -132 68 71% 23
10 LEE, Y , HAAS, KM , GOR, DO , DING, XD , KARP, DR , GREENSPAN, NS , POE, JC , TEDDER, TF , (2005) COMPLEMENT COMPONENT C3D-ANTIGEN COMPLEXES CAN EITHER AUGMENT OR INHIBIT B LYMPHOCYTE ACTIVATION AND HUMORAL IMMUNITY IN MICE DEPENDING ON THE DEGREE OF CD21/CD19 COMPLEX ENGAGEMENT.JOURNAL OF IMMUNOLOGY. VOL. 175. ISSUE 12. P. 8011 -8023 50 75% 34

Classes with closest relation at Level 1


Rank Class id link
1 9804 COMPLEMENT RECEPTOR 1//COMPLEMENT RECEPTOR TYPE 1//CR1
2 21318 ANTI R7V ANTIBODIES//C ADE//UNITE IMMUNORETROVIROL HUMAINE
3 11197 FOLLICULAR DENDRITIC CELLS//GERMINAL CENTER//CENTROCYTES
4 8410 CD59//CD55//CD46
5 2629 C2 DEFICIENCY//COMPLEMENT GENETICS//COMPLEMENT AND INFLAMMATION
6 10855 BZLF1//BRLF1//LYTIC CYCLE
7 11061 SURFACE IGM//MEMBRANE IMMUNOGLOBULIN//IG ALPHA
8 7462 CD23//SOLUBLE CD23//FC EPSILON RII
9 9035 B 1 CELLS//CD5 B CELLS//B 1A CELLS
10 724 LATENT MEMBRANE PROTEIN 1//LMP1//EPSTEIN BARR VIRUS

Go to start page